Airsculpt Technologies Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
11.2%projected annual EPS growth
Analyst Coverage
2analysts covering
FY Revenue (est.)
$153.2Mnext fiscal year
FY EPS (est.)
-$0.02next fiscal year
Monitoring Framework
Key Performance Indicators
Quarterly Revenue Quarterly39.4MTarget: 151000000 to 157000000 (Full Year 2026 Guidance)
Quarterly Case Volume Quarterly3.1K
Same Center Sales Growth Quarterly100.0%Target: Approximately 3% comparable growth for FY 2026
Adjusted EBITDA Quarterly3.3MTarget: 15000000 to 17000000 (Full Year 2026 Guidance)
Watch Items
- Classification of inter-company transactions and balancesTrigger: Delayed filing of the 2025 Form 10-KAction: Monitor SEC filings for the finalized and audited 2025 Form 10-K to ensure internal controls over financial reporting are remediated.
- Leverage and Debt ReductionTrigger: Gross debt of approximately $45.6 million as of March 31, 2026Action: Track subsequent debt paydowns and utilization of the at-the-market (ATM) offering program to manage liquidity.
- GLP-1 Related Aesthetic ProceduresTrigger: Emerging demand for skin tightening and fat removal post-GLP-1 weight lossAction: Evaluate the rollout and patient adoption of standalone skin tightening and skin removal pilots.
Research as of 20 Jun 2026